Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

938 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours.
Bokemeyer C, Schmoll HJ, Harstrick A, Illiger HJ, Metzner B, Räth U, Hohnloser J, Clemm C, Berdel W, Siegert W, et al. Bokemeyer C, et al. Eur J Cancer. 1993;29A(16):2225-31. doi: 10.1016/0959-8049(93)90211-w. Eur J Cancer. 1993. PMID: 8110490 Clinical Trial.
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
Rick O, Bokemeyer C, Beyer J, Hartmann JT, Schwella N, Kingreen D, Neureither S, Metzner B, Casper J, Wandt H, Hartmann F, Schmoll HJ, Derigs G, Gerl A, Berdel WE, Kanz L, Siegert W. Rick O, et al. Among authors: bokemeyer c. J Clin Oncol. 2001 Jan 1;19(1):81-8. doi: 10.1200/JCO.2001.19.1.81. J Clin Oncol. 2001. PMID: 11134198 Clinical Trial.
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Kollmannsberger C, Rick O, Derigs HG, Schleucher N, Schöffski P, Beyer J, Schoch R, Sayer HG, Gerl A, Kuczyk M, Spott C, Kanz L, Bokemeyer C. Kollmannsberger C, et al. Among authors: bokemeyer c. J Clin Oncol. 2002 Apr 15;20(8):2031-7. doi: 10.1200/JCO.2002.08.050. J Clin Oncol. 2002. PMID: 11956262 Clinical Trial.
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.
Bokemeyer C, Oechsle K, Honecker F, Mayer F, Hartmann JT, Waller CF, Böhlke I, Kollmannsberger C; German Testicular Cancer Study Group. Bokemeyer C, et al. Ann Oncol. 2008 Mar;19(3):448-53. doi: 10.1093/annonc/mdm526. Epub 2007 Nov 15. Ann Oncol. 2008. PMID: 18006893 Free article. Clinical Trial.
938 results